Upharmacia April 2017
immunoglobulin will be subjected to laboratory analysis( in terms of quality to ensure efficiency and safety).
5. In case the Draft is adopted, the laboratory analysis will also be conducted if for the last 2 years circulation of other series of medicinal products was banned, regardless of whether they were removed from circulation or not. Let us remind you that under the current Procedure the reason enough for laboratory analysis is a ban on circulation of medicinal products of other series( regardless of the period or the date of its introduction), which were withdrawn from circulation in due course.
6. It prescribed to cancel the requirement to obtain a conclusion on the same series of medicinal products on the following conditions: if series of medicinal product were imported as one batch for various commercial entities, are stored in one customs warehouse,( if necessary) with a positive laboratory test results of quality of samples taken from one of them. In this case, it is proposed to control such series of medicinal product only visually.
HEALTHCARE NEWS
The Reimbursement System was Launched
On Apr 1, the governmental program“ Affordable drugs” was officially launched in Ukraine. The program allows patients to receive certain drugs against cardiovascular diseases, asthma and diabetes for free or with surcharge. According to Vice Prime Minister of Ukraine, as on Apr 20, 2700 pharmacies throughout Ukraine joined the program, while their number is expected to grow. As on Apr 27, about 48 ths people in Kyiv used the program. The average cost of the prescription amounted UAH 40.
The PM of Ukraine said that the government could increase the funding of the program in 2017 by UAH 250 mio. Initially, UAH 500 mio were allocated for the program in 2017, which is only half of the minimum needed, according to estimates. The list of medicines, which fall under reimbursement, could also be expanded.
International Clinical Protocols will be used in Ukraine
The MOH approved the Order, which would allow Ukrainian physicians using international clinical protocols in providing medical aid since May 2017. However, additional time will be needed to translate and approve the protocols. The acting Head of the MOH stated that the Order would allow to publicly procure more modern and effective medicines. The Order is permissive in nature, so physicians will choose between national and international protocols.
The Deputy Head of the MOH
Olexandr Linchevskiy stated that the use of international protocols would stimulate pharmaceutical companies to register new medicines in Ukraine.“ If the producer sees, that clinical protocol, which foresees the use of a specific preparation, works in Ukraine, he will expand its portfolio,” Mr. Linchevskiy said.
MOH and NABU will Fight Corruption in Healthcare
On 28 Apr, the MOH signed Memorandum on cooperation with NABU( National Anti- Corruption Bureau of Ukraine) to form the basis of systematic cooperation in fight against corruption in the health sector.
“ We want the civil society to start making regular screenings on the ground to prevent corruption crimes,” the acting Head of the MOH Ulana Suprun
8 www. upharma-c. com